CLINICAL_TRIALS
trial_result
· 2024-12-06
Clinical Trial Update: Targeted Fluorescence Imaging in AMD [Phase 1]
Summary
Phase 1 clinical trial update on a targeted fluorescence imaging approach for age-related macular degeneration; the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Medical Center Groningen | Conditions: Age-Related Macular Degeneration, NAMD | Phase 1 | Status: COMPLETED